We generate our revenue by working new drugs through initial phases, sometimes to preclinical stages and sell them to Big Pharma companies.Get Started
To start with, start-ups are five times better at R&D productivity than big pharma which is why the latter pulled themselves out of that area from past decade and half. Small companies are currently dominating the early development of new medicines.
Secondly, big pharma companies are so rigidly structured. Bureaucracy, red-tapism, shift in priorities, Internal politics, frequent shuffle in teams, internal policy changes, low risk tolerance are just in the nature of big companies, constant vigilance from authorities, media and competitors had further weighed them down. Which is why they are becoming less of science and more of everything else. Operating to meet their stock goals.
So, Big Pharma companies are now collaborating and investing in start-ups and licensing technology to fuel their own drug pipelines. We are in association with some of those big pharma companies and offer our R&D services to expedite their projects.
AMR poses the greatest threat to humankind today killing more than 7,00,000 people every year and the numbers are increasing fast.
Exploiting features like Machine Learning, Deep Learning and Big data in our research has many promising uses from primary screening of medicinal compounds to the prediction of success rate of a new drug. AI and Big data play a huge role in reducing the whole R&D cycle time, improve accuracy and decrease overall operational costs.
Our company is also one the members of the prestigious AMR Industry alliance which is the largest private sector alliance formed in 2016 to fight Antimicrobial Resistance.
Whereas Counter-Cyclical Businesses does well when recession hits. BUT some industries stood out of this zone, the economic cycles do not affect them. These are called Acyclical Industries. Pharma is one such Industry.
Pharma industry stood out for its strong growth during the great recession and has proved resilient during previous recessions because of its defensive nature. Pharma industry is not dependent on consumption demand, because buying medicines is not a choice like buying a pair of shoes or a motor vehicle.